Mobile

A randomized phase II trial of pemetrexed with or without PF-3512676 for the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of one prior chemotherap...

Update Il y a 4 ans
Reference: EUCTR2006-001588-52

A randomized phase II trial of pemetrexed with or without PF-3512676 for the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of one prior chemotherapy regimen for advanced disease

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

- To assess Progression Free Survival (PFS) in patients randomized to pemetrexed plus PF-3512676 (Investigational Treatment) and in patients randomized to pemetrexed alone (Control Treatment Arm).

Inclusion criteria

  • Treatment of patients with locally advanced or metastatic non-small lung cancer (NSLC) after failure of one prior chemotherapy regimen for advanced disease

Links